Anima Biotech

Anima Biotech: Revolutionizing Drug Discovery with AI

Anima Biotech is at the forefront of AI-driven drug discovery, offering a groundbreaking "Biology GPU" platform that enables artificial intelligence models to interact directly with biological systems. This innovative technology bridges the gap between AI's analytical power and the complexities of cellular biology, paving the way for faster, more efficient development of new therapeutics.

What Anima Biotech Offers

• Biology GPU: This is the core of Anima's offering, serving as the experimental runtime for AI in drug discovery. It provides the infrastructure for AI models to "chat with cells" and reason experimentally about complex biological pathways.
• Visual Biology Automation: A proprietary visualization modality that captures biological pathways and mechanisms in action within cells at a scale suitable for AI analysis.
• Experimental Biology Runtime: A large-scale experimental infrastructure that allows AI models to perform computations and draw conclusions directly from cellular data.
• Visual Biology Model: An AI model trained on billions of proprietary pathway images, capable of recognizing active biological pathways in both healthy and diseased cells. This model can be deployed within a customer's private cloud environment.
• Agentic Chat Loop: This feature connects AI models, including Large Language Models (LLMs), to the Biology GPU infrastructure, creating an explainable reasoning loop grounded in real biological data. This facilitates the discovery of causal targets, mechanisms, and therapeutic approaches.
• Multimodal Disease Models: Anima builds comprehensive disease models that connect various data types, such as genomics and transcriptomics, to intracellular biological activity, providing AI with cell-specific biological grounding and mechanistic insights.
• mRNA Lightning Platform: Specialized capabilities for the discovery of target modulators through mRNA biology, powered by a dedicated mRNA neural network.